🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Terminated
Location
Paratek Recruiting Site
Start Date
2009-04-04
Trial ID
NCT00865280
Treatments Being Tested
This is a randomized, double-blind, double-dummy, multicenter, global Phase...
Status
Completed
Location
Trius investigator site 159
Start Date
2011-09-15
Trial ID
NCT01421511
The treatment of rifampicin-resistant/multidrug-resistant pulmonary tubercu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-30
Trial ID
NCT07191834
Linezolid is the first approved synthetic oxazolidinone that is active agai...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2010-11
Trial ID
NCT01295801
Results from previous studies have been inconclusive and the effect of line...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-03
Trial ID
NCT01544673
The purpose of our study is to determine the penetration of continuously in...
Status
Terminated
Location
Universitäsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin
Start Date
2006-11
Trial ID
NCT00435305
Treatments Being Tested
The INSPIRE-TB study is a pragmatic, multicentre, randomised, controlled, n...
Status
Recruiting
Location
Guiyang Public Health Treatment Center
Start Date
2022-05-23
Trial ID
NCT05081401
This open-label, prospective, multi-center, non-interventional, observation...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-17
Trial ID
NCT02991131
Treatments Being Tested
The objective of this study is to review the local management of patients w...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT01561469
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
Drug Research & Analysis Corp
Start Date
2007-12
Trial ID
NCT00646958